Profil
Christopher Beck is Senior Vice President-Operations at Context Therapeutics, Inc. since 2022.
Former positions include Vice President-Program Management at Galera Therapeutics, Inc., Aevi Genomic Medicine, Inc., and Formular Pharmaceuticals, Inc. Education includes an undergraduate degree from Drexel University and an MBA from The Pennsylvania State University.
Aktive Positionen von Christopher Beck
| Unternehmen | Position | Beginn |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Geschäftsführer | 05.01.2022 |
Ehemalige bekannte Positionen von Christopher Beck
| Unternehmen | Position | Ende |
|---|---|---|
| AEVI GENOMIC MEDICINE, INC. | Corporate Officer/Principal | - |
Formular Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
| GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Christopher Beck
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Galera Therapeutics, Inc.
Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of treatments for auto-immune pediatric disease | Health Technology |
Context Therapeutics, Inc.
Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Formular Pharmaceuticals, Inc. |
















